CYTOSAR-U vs DEPOCYT

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Attribute	CYTOSAR-U	DEPOCYT
Rating	56/100	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	CYTARABINE	CYTARABINE
Manufacturer	Teva	Pacira Pharms Inc
Dosage forms	Injectable	Injectable, Liposomal
Drug class	Nucleoside Metabolic Inhibitor	Nucleoside Metabolic Inhibitor
Boxed warning	None	None
Treats	Leukemia, Lymphoma, Meningeal Neoplasms	Leukemia, Lymphoma, Meningeal Neoplasms

cytosar-u depocyt

Rating

56/100

70/100

Pharmacy pays

—

Type

Active ingredient

CYTARABINE

Manufacturer

Teva

Pacira Pharms Inc

Dosage forms

Injectable

Injectable, Liposomal

Drug class

Nucleoside Metabolic Inhibitor

Boxed warning

None

Treats

Leukemia, Lymphoma, Meningeal Neoplasms

Frequently asked questions

Which is better-rated, Cytosar-U or Depocyt?

By our independent rating, Depocyt scores higher — 3.5 vs 2.8 out of 5 for Cytosar-U. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Cytosar-U and Depocyt?

Both Cytosar-U and Depocyt share the active ingredient Cytarabine.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.